Sanofi
SAN
Real-time Euronext Paris - 04/25 05:35:22 pm
65.87EUR
+0.69%
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines.

The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes & cardiovascular, established prescription products and generics, together with research, development and production activities.

This segment also includes all associates whose activities are related to pharmaceuticals.

The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for its Consumer Healthcare products, together with research, development and production activities dedicated to those products.

The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development and production activities dedicated to vaccines.

The company was founded on April 28, 1994 and is headquartered in Paris, France.

Number of employees : 106 566 persons.
Sales per Businesses
20162017
EUR
(in Million)
%EUR
(in Million)
%
Pharmaceuticals29,24486.5%25,12271.7%
Vaccines4,57713.5%5,10114.6%
Other----
Consumer Healthcare--4,83213.8%
Sales per Regions
20162017
EUR
(in Million)
%EUR
(in Million)
%
United States12,39136.6%11,85533.8%
Europe6,47319.1%7,19520.5%
Asia (Excluding South Asia)3,1099.2%--
Africa, Middle East and South Asia2,7648.2%2,3266.6%
Latin America2,5037.4%2,8378.1%
France2,2066.5%2,3306.6%
Japan1,6885%1,8035.1%
Eurasia1,0903.2%1,2423.5%
Rest of the World898.002.7%1,1883.4%
Other699.002.1%547.001.6%
Asia (Including South Asia)--3,73210.6%
Managers
- Chief Executive Officer & Director :
    Olivier Brandicourt
- Chairman :
    Serge Weinberg
- Chief Financial Officer & Executive VP-Finance :
    Jérôme Contamine
- President-Global Research & Development :
    Elias Zerhouni
- Executive Vice President-Medical Affairs :
    Ameet Nathwani
- Independent Director :
    Robert Castaigne
- Independent Director :
    Claudie Haigneré
- Independent Director :
    Carole Piwnica
- Independent Director :
    Suet-Fern Lee
- Director :
    Christian Mulliez
Company contact information
54 rue la Boétie
FR-75008 Paris
France

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
Internet : http://www.sanofi.com
Markets and indexes
- Euronext Paris
- Compartiment A
- CAC 40 / CAC All Shares, CAC All-Tradable, CAC Large 60, Euro Stoxx 50, Euronext 100, FTSE Eurotop 100, Low Carbon 100 Europe, PEA, Stoxx Europe 50, Stoxx France 50, Stoxx Global 200
Stock Exchange Codes
- ISIN Code :  FR0000120578
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:[email protected]
Overall rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision